Emergent Biosolutions secures $51.9M contract modification award for smallpox preparedness

4 hours ago 1

Emergent BioSolutions (NYSE:EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (OTCPK:ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness.
EBS +4.954% after hours to $7.21.
Source: Press Release

Recommended For You